Literature DB >> 10620635

Fruit and vegetable intakes and prostate cancer risk.

J H Cohen1, A R Kristal, J L Stanford.   

Abstract

BACKGROUND: There is extensive and consistent evidence that high fruit and vegetable intakes are associated with decreased risks of many cancers, but results for prostate cancer risk have been inconsistent. We studied the associations of fruit and vegetable intakes with prostate cancer risk in a population-based, case-control study of men under 65 years of age.
METHODS: Case participants were 628 men from King County (Seattle area), WA, who were newly diagnosed with prostate cancer. Control participants were 602 men recruited from the same underlying population and frequency matched to case participants by age. Self-administered food-frequency questionnaires were used to assess diet over the 3- to 5-year period before diagnosis or recruitment. Daily nutrient intakes were calculated by use of a nutrient database with recently updated analytic values for carotenoids. Odds ratios for prostate cancer risk associated with foods and nutrients were calculated by use of unconditional logistic regression.
RESULTS: No associations were found between fruit intake and prostate cancer risk. The adjusted odds ratio (ORs) for the comparison of 28 or more servings of vegetables per week with fewer than 14 servings per week was 0.65 (95% confidence interval [CI] = 0.45-0.94), with a two-sided P for trend =.01. For cruciferous vegetable consumption, adjusted for covariates and total vegetable intake, the OR for comparison of three or more servings per week with less than one serving per week was 0.59 (95% CI = 0.39-0.90), with a two-sided P for trend =.02. The OR for daily intake of 2000 microg or more lutein plus zeaxanthin compared with an intake of less than 800 microg was 0.68 (95% CI = 0.45-1.00).
CONCLUSION: These results suggest that high consumption of vegetables, particularly cruciferous vegetables, is associated with a reduced risk of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620635     DOI: 10.1093/jnci/92.1.61

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  117 in total

Review 1.  Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.

Authors:  Stephanie M Tortorella; Simon G Royce; Paul V Licciardi; Tom C Karagiannis
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo.

Authors:  Kozue Sakao; Sudhakar Desineni; Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Prostate       Date:  2011-12-07       Impact factor: 4.104

Review 3.  Mechanisms of action of isothiocyanates in cancer chemoprevention: an update.

Authors:  Sandi L Navarro; Fei Li; Johanna W Lampe
Journal:  Food Funct       Date:  2011-09-21       Impact factor: 5.396

4.  [Prevention of uro-oncological diseases].

Authors:  B J Schmitz-Dräger; G Lümmen; E Bismarck; C Fischer
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

5.  A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer.

Authors:  Elisabeth I Heath; Lance K Heilbrun; Jing Li; Ulka Vaishampayan; Felicity Harper; Pam Pemberton; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2010-07-23       Impact factor: 4.060

6.  Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects.

Authors:  Melinda C Myzak; Philip Tong; Wan-Mohaiza Dashwood; Roderick H Dashwood; Emily Ho
Journal:  Exp Biol Med (Maywood)       Date:  2007-02

7.  Genes involved in obesity: Adipocytes, brain and microflora.

Authors:  L Macia; O Viltart; C Verwaerde; M Delacre; A Delanoye; C Grangette; I Wolowczuk
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

8.  Inhibition of Glycolysis in Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate.

Authors:  Krishna B Singh; Eun-Ryeong Hahm; Lora H Rigatti; Daniel P Normolle; Jian-Min Yuan; Shivendra V Singh
Journal:  Cancer Prev Res (Phila)       Date:  2018-03-15

9.  Biological mediators of effect of diet and stress reduction on prostate cancer.

Authors:  Gordon A Saxe; Jacqueline M Major; Lindsey Westerberg; Srikrishna Khandrika; Tracy M Downs
Journal:  Integr Cancer Ther       Date:  2008-09       Impact factor: 3.279

10.  2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathways.

Authors:  Supriya Shah; Janet K Hess-Wilson; Siobhan Webb; Hannah Daly; Sonia Godoy-Tundidor; Jae Kim; Joanne Boldison; Yehia Daaka; Karen E Knudsen
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.